0000899866-15-000028.txt : 20150209
0000899866-15-000028.hdr.sgml : 20150209
20150209204632
ACCESSION NUMBER: 0000899866-15-000028
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150205
FILED AS OF DATE: 20150209
DATE AS OF CHANGE: 20150209
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000899866
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133648318
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 352 KNOTTER DRIVE
CITY: CHESHIRE
STATE: CT
ZIP: 06511
BUSINESS PHONE: 2037761790
MAIL ADDRESS:
STREET 1: 352 KNOTTER DRIVE
CITY: CHESHIRE
STATE: CT
ZIP: 06511
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BELL LEONARD
CENTRAL INDEX KEY: 0001231949
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-27756
FILM NUMBER: 15590192
MAIL ADDRESS:
STREET 1: C/O ALEXION PHARMACEUTICALS INC
STREET 2: 352 KNOTTER DRIVE
CITY: CHESHIRE
STATE: CT
ZIP: 06410
4
1
wf-form4_142353278262478.xml
FORM 4
X0306
4
2015-02-05
0
0000899866
ALEXION PHARMACEUTICALS INC
ALXN
0001231949
BELL LEONARD
C/O ALEXION PHARMACEUTICALS INC
352 KNOTTER DRIVE
CHESHIRE
CT
06410
1
1
0
0
CEO
Common Stock, par value $.0001 per share
2015-02-05
4
A
0
33990
0
A
958708
D
Common Stock, par value $.0001 per share
2015-02-09
4
S
0
8660
173.98
D
950048
D
On February 5, 2015, the Compensation Committee determined that the reporting person earned 33,990 Performance Share Units upon achievement of certain performance targets previously established by the Compensation Committee. 1/3 of such shares vested on February 5, 2015 and 1/3 vest on each subsequent anniversary.
This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $173.87 - $174.33. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
/s/ Michael Greco, Attorney-in-Fact for Leonard Bell
2015-02-09